MAD2L1 and breast carcinoma: Besides, overexpression of MAD2L1 leads to chromosomal instability in lung tumour cells, and is highly correlated with high levels of BRCA pathway activity and BRCA1/2 pathogenic mutations in breast cancer patients (46).